# cisatracurium besylate

NDC: 72785-0009
Generic name: cisatracurium besylate
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200212

FDA application: ANDA212171

## Active ingredients

- CISATRACURIUM BESYLATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72785-0009"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72785-0009
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e145a40e-b046-4064-b35e-0da40ff3703e